UA41283C2 - Похідні антибіотику а 40926 та способи їх одержання - Google Patents

Похідні антибіотику а 40926 та способи їх одержання

Info

Publication number
UA41283C2
UA41283C2 UA94005300A UA94005300A UA41283C2 UA 41283 C2 UA41283 C2 UA 41283C2 UA 94005300 A UA94005300 A UA 94005300A UA 94005300 A UA94005300 A UA 94005300A UA 41283 C2 UA41283 C2 UA 41283C2
Authority
UA
Ukraine
Prior art keywords
derivatives
antibiotics
obtaining
methods
alkylaminocarbonyl
Prior art date
Application number
UA94005300A
Other languages
English (en)
Inventor
Адріано Малабарба
Ромео Чабаті
Жанбатіста Панцоне
Алесандра Марія Маразі
Original Assignee
Біосерч Італіа С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA41283(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Біосерч Італіа С.П.А. filed Critical Біосерч Італіа С.П.А.
Publication of UA41283C2 publication Critical patent/UA41283C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Спосiб виробництва горiлки "Донецька" передбачає приготування виправленої води, цукрового розчину, купажування рецептурних компонентiв, фiльтрацiю купажу, коректування його міцності i розливу, причому розчинення рецептурної кiлькостi цукру в розрахунковiй кiлькостi виправленої води здiйснюють при температурi 28-32 °С i перемiшуваннi, а змiшування в купажнiй ємкостi цукрового розчину із спиртом етиловим ректіфікованим - при масовому співвідношенні цукру і спирту ректифікованого (0,84-1,16) - 155.
UA94005300A 1991-07-29 1992-07-14 Похідні антибіотику а 40926 та способи їх одержання UA41283C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12
PCT/EP1992/001594 WO1993003060A1 (en) 1991-07-29 1992-07-14 Amide derivatives of antibiotic a 40926

Publications (1)

Publication Number Publication Date
UA41283C2 true UA41283C2 (uk) 2001-09-17

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005300A UA41283C2 (uk) 1991-07-29 1992-07-14 Похідні антибіотику а 40926 та способи їх одержання

Country Status (24)

Country Link
EP (2) EP0596929B1 (uk)
JP (1) JP3418762B2 (uk)
KR (1) KR100242682B1 (uk)
AT (1) ATE125551T1 (uk)
AU (1) AU666862B2 (uk)
BG (1) BG61124B2 (uk)
CA (1) CA2109601C (uk)
CZ (1) CZ285703B6 (uk)
DE (1) DE69203724T2 (uk)
DK (1) DK0596929T3 (uk)
ES (1) ES2075709T3 (uk)
FI (1) FI112662B (uk)
GR (1) GR3017897T3 (uk)
HU (2) HU223946B1 (uk)
IE (1) IE68420B1 (uk)
IL (1) IL102623A (uk)
MX (1) MX9204394A (uk)
NO (1) NO314150B1 (uk)
NZ (1) NZ243735A (uk)
PL (1) PL171813B1 (uk)
RU (1) RU2125058C1 (uk)
TW (1) TW218021B (uk)
UA (1) UA41283C2 (uk)
WO (1) WO1993003060A1 (uk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
MY128335A (en) * 1994-01-28 2007-01-31 Lilly Co Eli Glycopeptide antibiotic derivatives
PT836619E (pt) * 1995-07-05 2004-11-30 Aventis Bulk S P A Purificacao de antibioticos dalba-heptidicos por focagem isoelectrica
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
SG87877A1 (en) * 1998-12-23 2002-04-16 Advanced Medicine Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
CN1249081C (zh) * 1998-12-23 2006-04-05 施万制药 糖肽衍生物或含有它们的药物组合物
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
DK1565201T3 (en) 2002-11-18 2019-02-25 Vicuron Pharmaceuticals Llc METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections
WO2004110473A1 (en) 2003-05-27 2004-12-23 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
DE602004010915T2 (de) 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
KR20070092719A (ko) 2004-11-29 2007-09-13 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 글리코펩타이드 항생 물질 모노머 유도체
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
WO2009081958A1 (ja) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. グリコペプチド抗生物質配糖化誘導体
KR20230130679A (ko) * 2021-01-11 2023-09-12 셀리아 파마슈티칼즈 에이피에스 합성 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
ES2083374T3 (es) * 1988-12-27 1996-04-16 Lepetit Spa Derivados amidicos en posicion c63 de 34-des(acetilglucosaminil)-34-desoxi-teicoplaninas.
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
CA2099866C (en) * 1991-03-27 2002-07-09 Rolf H. Hermann Antibiotic a 40926 ester derivatives

Also Published As

Publication number Publication date
JP3418762B2 (ja) 2003-06-23
PL171813B1 (pl) 1997-06-30
NO314150B1 (no) 2003-02-03
DE69203724T2 (de) 1996-01-18
HU9400256D0 (en) 1994-05-30
MX9204394A (es) 1993-01-29
IE922451A1 (en) 1993-02-10
FI940394A0 (fi) 1994-01-26
EP0596929A1 (en) 1994-05-18
IL102623A (en) 1996-10-16
NO934722L (no) 1994-02-14
EP0525499A1 (en) 1993-02-03
KR100242682B1 (ko) 2000-02-01
IL102623A0 (en) 1993-01-14
TW218021B (uk) 1993-12-21
ES2075709T3 (es) 1995-10-01
WO1993003060A1 (en) 1993-02-18
FI112662B (fi) 2003-12-31
HU211347A9 (en) 1995-11-28
CA2109601C (en) 2002-07-02
DK0596929T3 (da) 1995-09-11
GR3017897T3 (en) 1996-01-31
DE69203724D1 (de) 1995-08-31
NO934722D0 (no) 1993-12-20
FI940394A (fi) 1994-01-26
BG61124B2 (bg) 1996-11-29
JPH06509347A (ja) 1994-10-20
CZ285703B6 (cs) 1999-10-13
CZ19294A3 (en) 1994-11-16
RU2125058C1 (ru) 1999-01-20
CA2109601A1 (en) 1993-02-18
NZ243735A (en) 1995-01-27
ATE125551T1 (de) 1995-08-15
AU2326292A (en) 1993-03-02
IE68420B1 (en) 1996-06-12
EP0596929B1 (en) 1995-07-26
HUT66080A (en) 1994-09-28
AU666862B2 (en) 1996-02-29
HU223946B1 (hu) 2005-03-29

Similar Documents

Publication Publication Date Title
UA41283C2 (uk) Похідні антибіотику а 40926 та способи їх одержання
RU94013457A (ru) Амидные производные антибиотика а 40926
DE69434136D1 (de) Dolastatin-derivate
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
DK0582810T3 (da) Nye 7-(substitueret)-8-(substitueret)-9-(substitueret amino)-6-demethyl-6-deoxytetracycliner som antibiotiske midler
AU2415292A (en) Novel tetrapeptide derivative
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
ES2173391T3 (es) Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
NO890567D0 (no) Anthracyklin-derivater.
SE9003476D0 (sv) Novel isoindole derivatives and salts thereof, process for producing the same and antitumor agent comprising the same
ES2058737T3 (es) Derivados semisinteticos con actividad inmunomoduladora, apropiados para administracion oral o parenteral.
FI921339A (fi) Nya foereningar, benemda "leustroduksiner", deras framstaellning och terapeutiska anvaendningar
FI951378A0 (fi) N-asetyyli-neuramiinihapon johdannaisten synteesi
DE3881862T2 (de) Disaccharidderivate.
TW344743B (en) Therapeutic nucleosides
KR900006517A (ko) 항생제 pb-6042류
EP0596112A4 (en) Macrolide compound and its preparation.
EP0404104A3 (en) Angolamycin derivatives